Access to medicines in the developing world
On the 11th of July 2013, The Guardian acknowledged the general concern originating from the challenges and inefficiencies of actual global health supplies. In effect, the newspaper highlighted an important question raised by the Centre for Innovation in Healthcare Logistics (CIHL) at the University of Arkansas[2]in a Report on the US Healthcare industry´s supply chains: “How does Coca-Cola get to remote villages while essential medications can’t?” The main purpose of this article is to briefly analyse current issues related to the availability and affordability of medicines in the developing and less developed world.
